Geode Capital Management
AZN icon

Geode Capital Management’s AstraZeneca AZN Stock Holding History

Geode Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-243,123
Closed -$44.7M – 4524
2025
Q4 		$44.7M Sell
243,123
-8,614
-3% -$1.51M ﹤0.01% 1558
2025
Q3 		$38.6M Sell
251,737
-791
-0.3% -$120K ﹤0.01% 1645
2025
Q2 		$35.3M Buy
252,528
+7,013
+3% +$983K ﹤0.01% 1623
2025
Q1 		$36.1M Sell
245,515
-3,901
-2% -$564K ﹤0.01% 1567
2024
Q4 		$32.7M Buy
249,416
+2,692
+1% +$377K ﹤0.01% 1685
2024
Q3 		$38.4M Buy
246,724
+635
+0.3% +$103K ﹤0.01% 1602
2024
Q2 		$38.4M Sell
246,089
-1,840
-0.7% -$277K ﹤0.01% 1534
2024
Q1 		$33.6M Buy
247,929
+2,746
+1% +$364K ﹤0.01% 1616
2023
Q4 		$33M Sell
245,183
-355
-0.1% -$46.1K ﹤0.01% 1610
2023
Q3 		$33.3M Sell
245,538
-267
-0.1% -$36.5K ﹤0.01% 1505
2023
Q2 		$35.2M Buy
245,805
+1,020
+0.4% +$150K ﹤0.01% 1483
2023
Q1 		$34M Buy
244,785
+222
+0.1% +$29.9K ﹤0.01% 1453
2022
Q4 		$33.2M Buy
244,563
+6,058
+3% +$760K ﹤0.01% 1429
2022
Q3 		$26.2M Buy
238,505
+5,357
+2% +$680K ﹤0.01% 1541
2022
Q2 		$30.8M Sell
233,148
-21,644
-8% -$2.84M ﹤0.01% 1459
2022
Q1 		$33.2M Sell
254,792
-32,126
-11% -$3.85M ﹤0.01% 1545
2021
Q4 		$32.9M Buy
286,918
+22,024
+8% +$2.59M ﹤0.01% 1621
2021
Q3 		$31.2M Buy
264,894
+24,873
+10% +$2.9M ﹤0.01% 1665
2021
Q2 		$28.8M Sell
240,021
-33,534
-12% -$3.68M ﹤0.01% 1720
2021
Q1 		$27.2M Sell
273,555
-6,070
-2% -$610K ﹤0.01% 1680
2020
Q4 		$28M Buy
279,625
+853
+0.3% +$90.3K ﹤0.01% 1513
2020
Q3 		$30.6M Buy
278,772
+182,526
+190% +$20.3M 0.01% 1214
2020
Q2 		$10.2M Sell
96,246
-6,725
-7% -$695K ﹤0.01% 1911
2020
Q1 		$9.2M Buy
102,971
+2,412
+2% +$227K ﹤0.01% 1775
2019
Q4 		$10M Buy
100,559
+51,493
+105% +$4.85M ﹤0.01% 2007
2019
Q3 		$4.37M Buy
49,066
+24,208
+97% +$2.1M ﹤0.01% 2460
2019
Q2 		$2.05M Sell
24,858
-2,612
-10% -$205K ﹤0.01% 2934
2019
Q1 		$2.22M Sell
27,470
-2,137
-7% -$168K ﹤0.01% 2795
2018
Q4 		$2.25M Buy
29,607
+3,190
+12% +$249K ﹤0.01% 2713
2018
Q3 		$2.09M Buy
26,417
+1,073
+4% +$81.2K ﹤0.01% 2853
2018
Q2 		$1.78M Buy
25,344
+1,663
+7% +$120K ﹤0.01% 2921
2018
Q1 		$1.66M Buy
23,681
+2,712
+13% +$188K ﹤0.01% 2866
2017
Q4 		$1.46M Buy
20,969
+944
+5% +$63.7K ﹤0.01% 2935
2017
Q3 		$1.36M Buy
20,025
+3,466
+21% +$219K ﹤0.01% 2984
2017
Q2 		$1.13M Buy
16,559
+2,784
+20% +$182K ﹤0.01% 3053
2017
Q1 		$857K Sell
13,775
-2,748
-17% -$160K ﹤0.01% 3096
2016
Q4 		$902K Sell
16,523
-12,038
-42% -$684K ﹤0.01% 3044
2016
Q3 		$1.88M Sell
28,561
-3,960
-12% -$259K ﹤0.01% 2596
2016
Q2 		$1.96M Sell
32,521
-367
-1% -$21.3K ﹤0.01% 2495
2016
Q1 		$1.85K Sell
32,888
-4,964
-13% -$298K ﹤0.01% 2515
2015
Q4 		$2.57M Buy
37,852
+7,647
+25% +$501K ﹤0.01% 2306
2015
Q3 		$1.92M Buy
30,205
+3,690
+14% +$243K ﹤0.01% 2465
2015
Q2 		$1.69M Sell
26,515
-3,908
-13% -$268K ﹤0.01% 2604
2015
Q1 		$2.08M Buy
30,423
+3,763
+14% +$261K ﹤0.01% 2414
2014
Q4 		$1.88M Buy
26,660
+2,341
+10% +$168K ﹤0.01% 2473
2014
Q3 		$1.74M Buy
24,319
+6,096
+33% +$446K ﹤0.01% 2440
2014
Q2 		$1.35M Sell
18,223
-15,065
-45% -$1.09M ﹤0.01% 2611
2014
Q1 		$2.16M Sell
33,288
-9,889
-23% -$639K ﹤0.01% 2289
2013
Q4 		$2.56M Buy
43,177
+10,818
+33% +$588K ﹤0.01% 2142
2013
Q3 		$1.68M Sell
32,359
-2,662
-8% -$134K ﹤0.01% 2272
2013
Q2 		$1.66M Buy
+35,021
New +$1.78M ﹤0.01% 2153

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Geode Capital Management's AZN Position: Q1 2026 in Review

Geode Capital Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 243,123 shares — an estimated $44.7M sold.

Geode Capital Management first reported a position in AZN in Q2 2013 and held it in 51 quarters. The position peaked at $44.7M in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Geode Capital Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Geode Capital Management sold 243,123 AstraZeneca shares in Q1 2026, an estimated $44.7M.
  • Geode Capital Management first reported a position in AstraZeneca in Q2 2013 and held it in 51 quarters.
  • Geode Capital Management's AstraZeneca position peaked at $44.7M in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.